Latest research suggests the aryl hydrocarbon receptor binding to the SLC7A11 promoter boosts NSCLC progression via SLC7A11 expression activation, augmented cell oxidative sensitivity, and ferroptosis inhibition (40). This evidence concerns the gene SLC7A11 and non-small cell lung carcinoma.